-
1 Comment
Biosynex SA is currently in a long term uptrend where the price is trading 24.3% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
Based on the above factors, Biosynex SA gets an overall score of 2/5.
| ISIN | FR0011005933 |
|---|---|
| Sector | Healthcare |
| Industry | Medical Devices |
| Exchange | PA |
| CurrencyCode | EUR |
| PE Ratio | None |
|---|---|
| Target Price | 12.6 |
| Market Cap | 25M |
| Beta | 0.27 |
| Dividend Yield | None |
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALBIO.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
